795 related articles for article (PubMed ID: 25655581)
1. mRNA expression profiles in circulating tumor cells of metastatic colorectal cancer patients.
Mostert B; Sieuwerts AM; Bolt-de Vries J; Kraan J; Lalmahomed Z; van Galen A; van der Spoel P; de Weerd V; Ramírez-Moreno R; Smid M; Verhoef C; IJzermans JN; Gratama JW; Sleijfer S; Foekens JA; Martens JW
Mol Oncol; 2015 Apr; 9(4):920-32. PubMed ID: 25655581
[TBL] [Abstract][Full Text] [Related]
2. Circulating tumor cell isolation during resection of colorectal cancer lung and liver metastases: a prospective trial with different detection techniques.
Kaifi JT; Kunkel M; Das A; Harouaka RA; Dicker DT; Li G; Zhu J; Clawson GA; Yang Z; Reed MF; Gusani NJ; Kimchi ET; Staveley-O'Carroll KF; Zheng SY; El-Deiry WS
Cancer Biol Ther; 2015; 16(5):699-708. PubMed ID: 25807199
[TBL] [Abstract][Full Text] [Related]
3. mRNA and microRNA expression profiles in circulating tumor cells and primary tumors of metastatic breast cancer patients.
Sieuwerts AM; Mostert B; Bolt-de Vries J; Peeters D; de Jongh FE; Stouthard JM; Dirix LY; van Dam PA; Van Galen A; de Weerd V; Kraan J; van der Spoel P; Ramírez-Moreno R; van Deurzen CH; Smid M; Yu JX; Jiang J; Wang Y; Gratama JW; Sleijfer S; Foekens JA; Martens JW
Clin Cancer Res; 2011 Jun; 17(11):3600-18. PubMed ID: 21505063
[TBL] [Abstract][Full Text] [Related]
4. Clinico-pathological correlation of serial measurement of circulating tumor cells in 24 metastatic colorectal cancer patients receiving chemotherapy reveals interpatient heterogeneity correlated with CEA levels but independent of KRAS and BRAF mutation.
Das A; Kunkel M; Joudeh J; Dicker DT; Scicchitano A; Allen JE; Sarwani N; Yang Z; Kaifi J; Zhu J; Liao J; El-Deiry WS
Cancer Biol Ther; 2015; 16(5):709-13. PubMed ID: 25806877
[TBL] [Abstract][Full Text] [Related]
5. Improved Detection of Circulating Tumor Cells in Metastatic Colorectal Cancer by the Combination of the CellSearch® System and the AdnaTest®.
Gorges TM; Stein A; Quidde J; Hauch S; Röck K; Riethdorf S; Joosse SA; Pantel K
PLoS One; 2016; 11(5):e0155126. PubMed ID: 27182774
[TBL] [Abstract][Full Text] [Related]
6. A novel method for downstream characterization of breast cancer circulating tumor cells following CellSearch isolation.
Frithiof H; Welinder C; Larsson AM; Rydén L; Aaltonen K
J Transl Med; 2015 Apr; 13():126. PubMed ID: 25896421
[TBL] [Abstract][Full Text] [Related]
7. Molecular characteristics of circulating tumor cells resemble the liver metastasis more closely than the primary tumor in metastatic colorectal cancer.
Onstenk W; Sieuwerts AM; Mostert B; Lalmahomed Z; Bolt-de Vries JB; van Galen A; Smid M; Kraan J; Van M; de Weerd V; Ramírez-Moreno R; Biermann K; Verhoef C; Grünhagen DJ; IJzermans JN; Gratama JW; Martens JW; Foekens JA; Sleijfer S
Oncotarget; 2016 Sep; 7(37):59058-59069. PubMed ID: 27340863
[TBL] [Abstract][Full Text] [Related]
8. Prognostic and clinicopathological significance of circulating tumor cells detected by RT-PCR in non-metastatic colorectal cancer: a meta-analysis and systematic review.
Yang C; Zou K; Zheng L; Xiong B
BMC Cancer; 2017 Nov; 17(1):725. PubMed ID: 29115932
[TBL] [Abstract][Full Text] [Related]
9. Circulating tumor cell levels are elevated in colorectal cancer patients with high tumor burden in the liver.
Kaifi JT; Kunkel M; Dicker DT; Joude J; Allen JE; Das A; Zhu J; Yang Z; Sarwani NE; Li G; Staveley-O'Carroll KF; El-Deiry WS
Cancer Biol Ther; 2015; 16(5):690-8. PubMed ID: 25785486
[TBL] [Abstract][Full Text] [Related]
10. Circulating tumor cell detection: A prospective comparison between CellSearch® and RareCyte® platforms in patients with progressive metastatic breast cancer.
Dirix L; Buys A; Oeyen S; Peeters D; Liègeois V; Prové A; Rondas D; Vervoort L; Mariën V; Laere SV; Vermeulen P
Breast Cancer Res Treat; 2022 Jun; 193(2):437-444. PubMed ID: 35397078
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of circulating tumor cells (CTCs) in Egyptian non-metastatic colorectal cancer patients: A comparative study for four different techniques of detection (Flowcytometry, CellSearch, Quantitative Real-time PCR and Cytomorphology).
Bahnassy AA; Salem SE; Mohanad M; Abulezz NZ; Abdellateif MS; Hussein M; Zekri CAN; Zekri AN; Allahloubi NMA
Exp Mol Pathol; 2019 Feb; 106():90-101. PubMed ID: 30578762
[TBL] [Abstract][Full Text] [Related]
12. Association of a novel circulating tumor DNA next-generating sequencing platform with circulating tumor cells (CTCs) and CTC clusters in metastatic breast cancer.
Davis AA; Zhang Q; Gerratana L; Shah AN; Zhan Y; Qiang W; Finkelman BS; Flaum L; Behdad A; Gradishar WJ; Platanias LC; Cristofanilli M
Breast Cancer Res; 2019 Dec; 21(1):137. PubMed ID: 31801599
[TBL] [Abstract][Full Text] [Related]
13. Androgen receptor expression in circulating tumor cells of patients with metastatic breast cancer.
de Kruijff IE; Sieuwerts AM; Onstenk W; Jager A; Hamberg P; de Jongh FE; Smid M; Kraan J; Timmermans MA; Martens JWM; Sleijfer S
Int J Cancer; 2019 Aug; 145(4):1083-1089. PubMed ID: 30761532
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal enumeration and cluster evaluation of circulating tumor cells improve prognostication for patients with newly diagnosed metastatic breast cancer in a prospective observational trial.
Larsson AM; Jansson S; Bendahl PO; Levin Tykjaer Jörgensen C; Loman N; Graffman C; Lundgren L; Aaltonen K; Rydén L
Breast Cancer Res; 2018 Jun; 20(1):48. PubMed ID: 29884204
[TBL] [Abstract][Full Text] [Related]
15. Global gene expression profiling of circulating tumor cells.
Smirnov DA; Zweitzig DR; Foulk BW; Miller MC; Doyle GV; Pienta KJ; Meropol NJ; Weiner LM; Cohen SJ; Moreno JG; Connelly MC; Terstappen LW; O'Hara SM
Cancer Res; 2005 Jun; 65(12):4993-7. PubMed ID: 15958538
[TBL] [Abstract][Full Text] [Related]
16. Cytokeratin-20 and Survivin-Expressing Circulating Tumor Cells Predict Survival in Metastatic Colorectal Cancer Patients by a Combined Immunomagnetic qRT-PCR Approach.
Ning Y; Hanna DL; Zhang W; Mendez A; Yang D; El-Khoueiry R; Matsusaka S; Sunakawa Y; Stremitzer S; Parekh A; Okazaki S; Berger MD; Barzi A; Lenz HJ
Mol Cancer Ther; 2015 Oct; 14(10):2401-8. PubMed ID: 26227487
[TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor receptor mRNA expression: A potential molecular escape mechanism from regorafenib.
Matsusaka S; Hanna DL; Ning Y; Yang D; Cao S; Berger MD; Miyamoto Y; Suenaga M; Dan S; Mashima T; Seimiya H; Zhang W; Lenz HJ
Cancer Sci; 2020 Feb; 111(2):441-450. PubMed ID: 31821662
[TBL] [Abstract][Full Text] [Related]
18. Gene expression analysis of bone metastasis and circulating tumor cells from metastatic castrate-resistant prostate cancer patients.
Cho WJ; Oliveira DS; Najy AJ; Mainetti LE; Aoun HD; Cher ML; Heath E; Kim HR; Bonfil RD
J Transl Med; 2016 Mar; 14():72. PubMed ID: 26975354
[TBL] [Abstract][Full Text] [Related]
19. Clinical relevance of EMT and stem-like gene expression in circulating tumor cells of metastatic colorectal cancer patients.
Ning Y; Zhang W; Hanna DL; Yang D; Okazaki S; Berger MD; Miyamoto Y; Suenaga M; Schirripa M; El-Khoueiry A; Lenz HJ
Pharmacogenomics J; 2018 Jan; 18(1):29-34. PubMed ID: 27503579
[TBL] [Abstract][Full Text] [Related]
20. mRNA-Seq of single prostate cancer circulating tumor cells reveals recapitulation of gene expression and pathways found in prostate cancer.
Cann GM; Gulzar ZG; Cooper S; Li R; Luo S; Tat M; Stuart S; Schroth G; Srinivas S; Ronaghi M; Brooks JD; Talasaz AH
PLoS One; 2012; 7(11):e49144. PubMed ID: 23145101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
